Preventing atherosclerosis the underlying cause of heart disease
Preventing atherosclerosis, the underlying cause of heart disease, means scientists need to understand how immune cells drive inflammation in the arteries. The challenge is that the T cells involved in atherosclerosis are very rare and extremely hard to find in the bloodstream. “This is a classic needle-in-the-haystack problem,” says La Jolla Institute for Immunology (LJI) […]
Study: App more accurate than patient evaluation of stool samples
An innovative mobile phone application was found to be as good as expert gastroenterologists at characterizing stool specimens, according to a study by Cedars-Sinai. The artificial intelligence (AI) used in the smartphone app also outperformed reports by patients describing their stool specimens. Stool reporting by patients, usually guided by the Bristol Stool Scale, is crucial […]
Cannabis users require more sedation for endoscopy
Patients who use cannabis required higher levels of sedation during gastric endoscopies than non-users, according to research to be presented at Digestive Disease Week (DDW) 2022. As cannabis is legalized in more places and usage rises, clinicians should be aware of patients’ habits and prepare themselves and their patients for increased sedation and accompanying risks, […]
Mounjaro approved for blood glucose control in type 2 diabetes
Mounjaro (tirzepatide) injection was approved as an addition to diet and exercise to improve blood glucose control in adults with type 2 diabetes, the U.S. Food and Drug Administration announced May 13. The first-in-class medicine works by activating glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors and is administered by injection under the skin once a […]
Regulatory, patent reform needed for inhalers for asthma, COPD
Of the 62 inhalers approved by the U.S. Food and Drug Administration since 1986, few have offered novel drug innovations, according to a study published online May 17 in Health Affairs. Noting that inhalers face limited generic competition in the United States, William B. Feldman, M.D., D.Phil., from Brigham and Women’s Hospital in Boston, and […]